Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sandler

Showing results (281-290 of 321) with videos related to

Pageof 33
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2009
A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC)Anshu K Jain, Randall S Hughes, Alan B Sandler, et al.
Infection Control and Hospital Epidemiology|June 1, 1999
Agrobacterium radiobacter as a cause of pseudobacteremiaA M Rogues, J Sarlangue, B de Barbeyrac, et al.
Clinical Lung Cancer|January 17, 2004
Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trialM A Socinski, A B Sandler, L L Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599Suresh S Ramalingam, Suzanne E Dahlberg, Corey J Langer, et al.
The Oncologist|October 25, 2023
The Landscape of US and Global Rare Tumor Research Programs: A Systematic ReviewChristina Vivelo, Karlyne M Reilly, Brigitte C Widemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancerM A Socinski, A B Sandler, L L Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Steps and time to process clinical trials at the Cancer Therapy Evaluation ProgramDavid M Dilts, Alan B Sandler, Steven K Cheng, et al.
Human Antibodies and Hybridomas|January 1, 1996
Comparative study of the role of serum levels of p53 antigen and its tumor cell concentration in colon cancer detectionI Zusman, B Sandler, P Gurevich, et al.
Resuscitation|August 18, 2019
Pauses in compressions during pediatric CPR: Opportunities for improving CPR qualityKaren J O'Connell, Ryan R Keane, Niall H Cochrane, et al.
Cancer|September 19, 2002
Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinomaMark A Socinski, Alan B Sandler, Valerie K Israel, et al.
Pageof 33

Showing results (281-290 of 321) with videos related to

Sort By:
Pageof 33
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2009
A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC)Anshu K Jain, Randall S Hughes, Alan B Sandler, et al.
Infection Control and Hospital Epidemiology|June 1, 1999
Agrobacterium radiobacter as a cause of pseudobacteremiaA M Rogues, J Sarlangue, B de Barbeyrac, et al.
Clinical Lung Cancer|January 17, 2004
Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trialM A Socinski, A B Sandler, L L Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599Suresh S Ramalingam, Suzanne E Dahlberg, Corey J Langer, et al.
The Oncologist|October 25, 2023
The Landscape of US and Global Rare Tumor Research Programs: A Systematic ReviewChristina Vivelo, Karlyne M Reilly, Brigitte C Widemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancerM A Socinski, A B Sandler, L L Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Steps and time to process clinical trials at the Cancer Therapy Evaluation ProgramDavid M Dilts, Alan B Sandler, Steven K Cheng, et al.
Human Antibodies and Hybridomas|January 1, 1996
Comparative study of the role of serum levels of p53 antigen and its tumor cell concentration in colon cancer detectionI Zusman, B Sandler, P Gurevich, et al.
Resuscitation|August 18, 2019
Pauses in compressions during pediatric CPR: Opportunities for improving CPR qualityKaren J O'Connell, Ryan R Keane, Niall H Cochrane, et al.
Cancer|September 19, 2002
Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinomaMark A Socinski, Alan B Sandler, Valerie K Israel, et al.
Pageof 33